Abstract
Food intake exerts a complex influence on the bioavailability of drugs. It may interfere not only with tablet disintegration, drug dissolution and drug transit through the gastrointestinal tract, but may also affect the metabolic transformation of drugs in the gastrointestinal wall and in the liver. Different food components can have different effects, and food may interact in opposite ways, even with drugs that are chemically related. Therefore, the net effect of food on drug bioavailability can be predicted only by direct clinical studies of the drug in question.
As judged mainly from single meal, single dose studies, food intake enhances the bioavailability of several different drugs, such as propranolol, metoprolol, hydrallazine, hydrochlorothiazide, canrenone (from spironolactone), nitrofurantoin, erythromycin (stearate), dicoumarol, phenytoin and carbamazepine, but reduces that of drugs such as isoniazid, rifampicin, tetracycline, penicillin and ampicillin, while having no consistent effect on the bioavailability of metronidazole, oxazepam, melperone, propylthiouracil, sulphasomidine and sulphonylureas. For some drugs such as digoxin and paracetamol, the rate but not the extent of absorption is reduced.
Food may enhance bioavailability even though, or rather because, the rate of gastric emptying is reduced; this is apparently the case with hydrochlorolhiazide and nitrofurantoin. The food induced enhancement of bioavailability of propranolol, metoprolol and hydrallazine is probably due to reduced first pass metabolism of these drugs, while food induced improvement of drug dissolution may explain the enhanced bioavailability of carbamazepine, canrenone, dicoumarol and phenytoin. An increased gastrointestinal pH may be in part the cause of the food induced reduction of the bioavailability of drugs such as isoniazid and tetracycline.
In addition to single meal effects, repeated intake of protein-rich meals enhance, while carbohydrate-rich meals reduce, the rate of oxidation of antipyrine and theophylline. Moreover, intake of charcoal broiled meat markedly accelerates the oxidation of phenacetin and variably accelerates elimination of theophylline. Thus, food and its components and contaminants may have both short and long term effects on both the absorptive and biotransformation processes influencing systemic availability of drugs.
Similar content being viewed by others
References
Acocella, G.: Clinical pharmacokinetics of rifampicin. Clinical Pharmacokinetics 3: 128–143 (1978).
Barr, W.H.; Adir, J. and Garrettson, L.: Decrease of tetracycline absorption in man by sodium bicarbonate. Clinical Pharmacology and Therapeutics 12: 779–784 (1971).
Bates, T.R.; Sequeira, J.A. and Tembo, A.V.: Effect of food on nitrofurantoin absorption. Clinical Pharmacology and Therapeutics 16: 63–68 (1974).
Bauer, G.; Rieckmann, P. and Schaumann, W.: Einfluss von Teilchengrosse und Losungsvermittlern auf die Resorption von Spironolacton aus dem Magen-Darmtrakt. Arzneimittel-Forschung 12: 487–489 (1962).
Beermann, B. and Groschinsky-Grind, M.: Gastrointestinal absorption of hydrochlorothiazide enhanced by concomitant intake of food. European Journal of Clinical Pharmacology. In press (1978a).
Beermann, B. and Groschinsky-Grind. M.: Enhancement of the gastrointestinal absorption of hydrochlorothiazide by propantheline. European Journal of Clinical Pharmacology. In press (1978b).
Binns, T.B.: Absorption and Distribution of Drugs (Livingstone. London 1964).
Bogentoft, C.; Carlsson. I.: Ekenved, G. and Magnusson, A.: Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms. European Journal of Clinical Pharmacology. In press (1978).
Chasseaud, L.F. and Taylor, T.: Bioavailability of drugs from formulations after oral administration. Annual Review of Pharmacology 14: 35–46 (1974).
Conney, A.H.; Pantuck, E.J.; Hsiao, K.-C.; Carland, W.A.; Anderson, K.E.; Alvares, A.P. and Kappas, A.: Enhanced phenacetin metabolism in human subjects fed charcoal-broiled beef. Clinical Pharmacology and Therapeutics 20: 633–642 (1976).
Crounse, R.G.: Effective use of griseofulvin. Archives of Dermatology 87: 176–180 (1963).
Curry, S.H.; D’mello, A. and Mould, G.P.: Destruction of chlorpromazine during absorption in the rat in vivo and in vitro. British Journal of Pharmacology 42: 403–411 (1971).
Dahl, S.G. and Strandjord, R.E.: Pharmacokinetics of chlorpromazine after single and chronic dosage. Clinical Pharmacology and Therapeutics 21: 437–448 (1977).
Doluisio, J.T.; La Piana, J.C.; Vilkinson, G.R. and Dittert, L.W.: Pharmacokinetic interpretation of dicloxacillin levels in serum after extravascular administration. Antimicrobial Agents and Chemotherapy 9: 49–55 (1969).
Editorial: Food and the handling of drugs. British Medical Journal 1: 1304 (1977).
Ervik, M.: Quantitative determination of metoprolol in plasma and urine by gas chromatography. Acta Pharmacologica et Toxicologica 36 (Suppl. 5): 136–144 (1975).
Fiegler, D.I.; Dryant, M.; Burley, D.M.; Citron, K.M. and Standen, S.M.: Effect of meals on rifampicin absorption. Lancet 2: 197–198 (1974).
Greenblatt, D.J.; Duhme, D.W.; Koch-Weser, J. and Smith, T.W.: Bioavailability of digoxin tablets and elixir in the fasting and postprandial states. Clinical Pharmacology and Therapeutics 16: 444–449 (1974).
Heading, R.C.; Nimmo, J.; Prescott, L.F. and Tothill, P.: The dependence of paracetamol absorption on the rate of gastric emptying. British Journal of Pharmacology 47: 415–421 (1973).
Hirsch, H.H. and Finland, M.: Effect of food on the absorption of erythromycin Propionate, erythromycin stearate and triacetyloleandomycin. American Journal of Medical Science 237: 693–699 (1959).
Hurwitz, A.: Antacid therapy and drug kinetics. Clinical Pharmacokinetics 2: 269–280 (1977).
Hurwitz, A. and Schlozman, D.L.: Effects of antacids on gastrointestinal absorption of isoniazid in rat and man. American Review of Respiratory Diseases 109: 41–44 (1974).
Jaffe, J.M.: Effect of propantheline on nitrofurantoin absorption. Journal of Pharmaceutical Sciences 64: 1725 (1975).
Jaffe, J.M.; Coliazzi, J.L. and Barry, H.: Effects of dietary components on gastrointestinal absorption of acetaminophen tablets in man. Journal of Pharmaceutical Sciences 60: 1646–1650 (1971).
Jenne, J.W.; Partial purification and properties of the isoniazid transacetylase in human liver. Its relationship to the acetylation of p-aminosalicylic acid. Journal of Clinical Investigation 44: 1992–2001 (1965).
Johansson, O.; Lindberg, T. and Melander, A.: On the mechanism of Phenytoin absorption from rat small intestine. European Journal of Clinical Investigation. Submitted for publication (1978).
Johnson, B.F.; O’Grady, J.; Sabey, G.A. and Bye, C.: Effect of a standard breakfast on digoxin absorption in normal subjects. Clinical Pharmacology and Therapeutics 23: 315–319 (1978).
Jordan, M.C.; de Maine, J. and Kirby, W.: Clinical pharmacology of pivampicillin as compared with ampicillin. Antimicrobial Agents and Chemotherapy 2: 438–441 (1970).
Kamme, C.; Kahlmeter, G. and Melander, A.: Evaluation of spiramycin as a therapeutic agent for elimination of nasopharyngeal pathogens. Possible use of spiramycin for middle ear infections and for gonococcal and meningococcal nasopharyngeal carriage. Scandinavian Journal of Infectious Diseases. In press (1978).
Kappas, A.; Anderson, K.E.; Conney, A.H. and Alvares, A.P.: Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man. Clinical Pharmacology and Therapeutics 20: 643–653 (1976).
Kappas, A.; Alvares, A.P.; Anderson, K.E.; Pantuck, E.J.; Pantuck, C.B.; Chang, R. and Conney, A.H.: Effect of charcoalbroiled beef on antipyrine and theophylline metabolism. Clinical Pharmacology and Therapeutics 23: 445–450 (1978).
Katchen, B.: Correlation of dissolution rate and drug absorption in man. Acta Pharmacologica et Toxicologica 29 (Suppl. 3): 88–95 (1971).
Kirby, W.M.M.; Roberts, C.E. and Burdick, R.E.: Comparison of two new tetracyclines with tetracycline and demethylchlortetracycline. Antimicrobial Agents and Chemotherapy 1: 286–292 (1961).
Klein, J.O. and Finland, M.: Medical progress: The new penicillins. New England Journal of Medicine 269: 1019–1024 (1963).
Koch-Weser, J.: Bioavailability of drugs. New England Journal of Medicine 291: 233–237. 503–506 (1974).
Lesser, J.M.; Israili, Z.H.; Davis, D.C. and Dayron, P.G.; Metabolism and disposition of hydralazine-14C in man and dog. Drug Metabolism and Disposition 2: 351–360 (1974).
Levine, R.R.: Factors affecting gastro-intestinal absorption of drugs. American Journal of Digestive Diseases 15: 171–180 (1970).
Levy, R.H.; Pitlick, W.H.; Troupin, A.S.; Green, J.R. and Neal, J.M.: Pharmacokinetics of carbamazepine in normal man. Clinical Pharmacology and Therapeutics 17: 657–668 (1975).
Linnoila, M.; Korttila, K. and Mattila, M.J.; Effect of food and repeated injections on serum diazepam levels. Acta Pharmacologica et Toxicologica 36: 181–186 (1975).
Macdonald, H.; Place, V.A.; Falk, H. and Darken, M.A.: Effect of food on absorption of Sulfonamides in man. Chemotherapia 12: 282–285 (1967).
McGilveray, I.J. and Mattok, G.L.: Some factors affecting the absorption of paracetamol. Journal of Pharmacy and Pharmacology 24: 615–619 (1972).
Mattok, G.L. and McGilveray, I.J.: The effect of food intake and sleep on the absorption of acetaminophen. Revue Canadienne de Biologie 32: 77–84 (1973).
Malmborg, A.-S.: Absorption of erythromycin stearate after oral administration. Current Medical Research and Opinion 5 (Suppl. 2): 15–18 (1978).
Melander, A.: Enhancement of hydralazine bioavailability by concomitant intake of food; in Pharmacological and clinical aspects of hydralazine (Apresoline) in today’s treatment of hypertension. Symposium. Oslo. 1977; Hassle-Ciba-Geigy A/S. Strammen. Norway, In press (1978).
Melander, A.; Brante, G.; Johansson, O.; Lindberg, T. and Wahlin, E.; Influence of food intake on the absorption of Phenytoin in man. European Journal of Clinical investigation. Submitted for publication (1978a).
Melander, A.; Haglund, G.: Larsson, H. and Molander, L.: Singledose kinetics of melperone: influence of food intake and of age. Manuscript in preparation (1978b).
Melander, A.; Berlin-Wahlen, A.; Bodin, N.-O.; Danielson, K.; Gustafsson, B.; Lindgren, S. and Westerlund, D.: Bioavailability of D-propoxyphene, acetyl salicylic acid, and Phenazone in a combination tablet (Doleron): interindividual variation and influence of food intake. Acta Medica Scaridinavica 202: 119–124 (1977f).
Melander, A.; Danielson, K.; Hanson, A.; Jansson, L.; Rerup, C.; Schersten, B.; Thulin, T. and Wahlin, E.: Reduction of isoniazid bioavailability in normal men by concomitant intake of food. Acta Medica Scandinavica 200: 93–97 (1976a).
Melander, A.; Wahlin, E.; Danielson, K. and Rerup, C.: On the influence of concomitant food intake on Sulfonamide bioavailability. Acta Medica Scandinavica 200: 497–500 (1976b).
Melander, A.; Danielson, K.; Hanson, A.; Rudell, B.; Schersten, B.; Thulin, T. and Wahlin, E.: Enhancement of hydralazine bioavailability by food. Clinical Pharmacology and Therapeutics 22: 104–107 (1977a).
Melander, A.; Danielson, K.; Schersten, B.; Thulin, T. and Wahlin, E.: Enhancement by food of canrenone bioavailability from Spironolactone. Clinical Pharmacology and Therapeutics 22: 100–103 (1977b).
Melander, A.; Danielson, K.; Schersten, B. and Wahlin, E.: Enhancement of the bioavailability of Propranolol and metoprolol by food. Clinical Pharmacology and Therapeutics 22: 108–112 (1977c).
Melander, A.; Danielson, K.; Vessman, J. and Wahlin, E.: Bioavailability of oxazepam: absence of influence of food intake. Acta Pharmacologica et Toxicologica 40: 584–588 (1977e).
Melander, A.; Kahlmeter, G.; Kamme, C. and Ursing, B.: Bioavailability of metronidazole in fasting and non-fasting healthy subjects and in patients with Crohn’s disease. European Journal of Clinical Pharmacology 12: 69–72 (1977d).
Melander, A. and Wahlin, E.: Enhancement of dicumarol bioavailability by concomitant food intake. European Journal of Clinical Pharmacology. Submitted for publication (1978).
Melander, A.; Wahlin, E.; Danielson, K. and Hanson, A.: Bioavailability of Propylthiouracil: interindividual variation and influence of food intake. Acta Medica Scandinavica 201: 41–44 (1977g).
Mitchison, D.A.: Plasma concentrations of isoniazid in the treatment of tuberculosis; in Davies and Pritchard (Eds) Biological effects of drugs in relation to their plasma concentrations, p.169–182 (Macmillan. London 1973).
Neu, H.C. Antimicrobial activity and human pharmacology of amoxycillin. Journal of Infectious Diseases 129 (Suppl.) 123 (June 1974).
Neuvonen, P.J.: Interactions with the absorption of tetracyclines. Drugs 11: 45–54 (1976).
Neuvonen, P.J. and Turakka, H.: Inhibitory effect of various iron salts on the absorption of tetracycline in man. European Journal of Clinical Pharmacology 7: 357–360 (1974).
Pierpaoli, P.G.: Drug therapy and diet. Drug Intelligence and Clinical Pharmacy 6: 89–99 (1972).
Prescott, L.F.: Gastrointestinal absorption of drugs. Medical Clinics of North America 58: 907–916 (1974).
Roholt, K.; Nielsen, B. and Kristensen, E.: Clinical pharmacology of pivampicillin. Antimicrobial Agents and Chemotherapy 6: 563–571 (1974).
Rosenberg, H.A. and Bates, T.R.: The influence of food on nitrofurantoin bioavailability. Clinical Pharmacology and Therapeutics 20: 227–232 (1976).
Sanchez, N.; Sheiner, L.B.. Halkin, H. and Melmon, K.L.: Pharmacokinetics of digoxin: interpreting bioavailability. British Medical Journal 4: 132–136 (1973).
Sartor, G.; Melander, A.; Schersten, B. and Wahlin, E.: Influence of food intake on the kinetics and effects of sulfonylurea drugs in healthy subjects and in diabetic patients; in Selected Topics in Diabetes. Proceedings of an International Meeting, Tirrenia, Italy, 1977 pp.129–139 (Carlo Erba, Milan 1978a).
Sartor, G.; Schersten, B. and Melander, A.: Effects of glipizide and food intake on the blood levels of glucose and insulin in diabetic patients. Acta Medica Scandinavica 203: 211–214 (1978b).
Shand, D.G.: Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs. Drug 7: 39–47 (1974).
Smith, R.B.; Dittert, L.W.; Griffen, Jr. W.O. and Doluisio,. J.T.: Pharmacokinetics of pentobarbital after intravenous and oral administration. Journal of Pharmacokinetics and Biopharmaceutics 1: 5–15 (1973).
Sutter, J.L. and Lan, E.P.K.: Spironolactone: in Florey, K. (Ed) Analytical Profiles of Drug Substances, vol. 4, p.411 (Academic Press. New York 1975).
Ther, L. and Winne, D.: Drug absorption. Annual Review of Pharmacology 11: 57–70 (1971).
Wagner, J.G.: Drug bioavailability studies. Hosnital Practice 12: 119–127 (1977).
Welling, P.G.: How food and fluid affect drug absorption. Postgraduate Medicine 62: 73–82 (1977).
Welling, P.G.; Lyons, L.L.; Craig, W.A. and Trochia, B.S.: Influence of diet and fluid on bioavailability of theophylline. Clinical Pharmacology and Therapeutics 17: 475–480 (1975).
White, R.J.; Chamberlain, D.S.; Howard, M. and Smith, T.W.: Plasma concentrations of digoxin after oral administration in the fasting and postprandial state. British Medical Journal 1: 380–381 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Melander, A. Influence of Food on the Bioavailability of Drugs. Clin Pharmacokinet 3, 337–351 (1978). https://doi.org/10.2165/00003088-197803050-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-197803050-00001